Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC considers innovation and research goals in strategy relaunch:

This article was originally published in Clinica

Executive Summary

Promoting innovation and sustainability is one of the main goals enshrined in the proposed relaunch of the European Commission's Lisbon Strategy, which aims to improve the competitiveness of the EU economy. The original Strategy had lost momentum and a draft internal Commission document has called for a refocus and relaunch along more targeted lines. The Commission's competitiveness group, which drafted the report, proposes that the strategy should be repositioned around 10 central policy areas which include, as well as innovation and sustainability, more and better research and development, completing the internal market and creating conditions for a strong European base.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054095

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel